Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

- Numax Achieves Primary Endpoint Among High-Risk Infants Versus Current Standard of Care and Shows Reduction of Medically Attended Outpatient RSV- Related Lower Respiratory Infections -

TORONTO, May 08, 2007 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced positive results from a large prospective trial conducted for prevention of respiratory syncytial virus (RSV). The trial compared motavizumab, the investigational monoclonal antibody (MAb) also known as Numax(R), with Synagis(R) (palivizumab), the standard of care for preventing RSV hospitalization in high-risk infants. In the Phase 3 study involving 6,635 pre-term infants at high risk for RSV, with a primary endpoint of non- inferiority, motavizumab demonstrated overall 26-percent fewer RSV hospitalizations compared with Synagis (p<0.01 for non-inferiority). Additionally, motavizumab demonstrated a statistically significant 50 percent reduction in the incidence of RSV-specific medically attended outpatient lower respiratory infections (LRIs) (p<0.01) compared with Synagis. These findings were presented today in a poster entitled, Phase 3 Trial of Motavizumab, an Enhanced Potency RSV-Specific MAb for the Prevention of Serious RSV Disease in High-Risk Infants, at the Pediatric Academic Societies' Annual Meeting in Toronto, Canada.

"As RSV continues to be the leading cause of lower respiratory tract infections in infants in the United States, we are very encouraged by the results of this Phase 3 trial, which suggest that motavizumab may help to reduce the chance that our most vulnerable babies will have serious RSV disease," said Edward M. Connor, M.D., chief medical officer and executive vice president. "Data from the study showed that motavizumab was statistically superior to Synagis for the secondary endpoint of outpatient medically attended LRI caused by RSV, and thus may reduce the overall burden of RSV disease compared to the current stan
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/23/2014)... July 23, 2014  ArmaGen, a privately held ... treat severe neurological disorders, announced today that it ... agreement with Shire plc to develop AGT-182, an ... of both the central nervous system (CNS) and ... as MPS II, Hunter syndrome is a rare, ...
(Date:7/23/2014)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a ... , announced today that it has been selected by the ... be a supplier of the seasonal influenza vaccine to the ... The Beijing CDC plans to order a minimum of ... from four domestic vaccine manufacturers for its vaccination campaign. Each ...
(Date:7/23/2014)... , Indien, July 23, 2014 ... scope für Arbeiten für Sadara Chemical Company ... Engineering Information System innerhalb des integrierten Chemiekomplexes ... award of additional scope im Wert von ... zuvor abgeschlossenen Vertrags dar, dessen Wert sich ...
Breaking Medicine Technology:ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4
... WASHINGTON, Aug. 17 The American Pharmacists Association (APhA) ... to consider their local pharmacy as the site to ... the District of Columbia are authorized to administer influenza ... 120,000 U.S. pharmacists have been trained to administer immunizations. ...
... 17 Varian Medical Systems, Inc. (NYSE: ... technology on its Trilogy® machine with advanced motion management ... Beijing August 19-21 by China,s Ministry of Health.  Varian, ... cancer and a premier supplier of X-ray imaging technology, ...
Cached Medicine Technology:Consumers Encouraged to Get Immunized Against Influenza 2Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010 2Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010 3
(Date:7/23/2014)... SafeUseNow? , a prescription drug ... Principled Strategies , today announced a service ... Utilizing SafeUseNow’s patent-pending risk model, Partnership HealthPlan can ... abusing controlled substance drugs, particularly prescription opioids, helping ... , The agreement with Partnership HealthPlan was made ...
(Date:7/23/2014)... 23, 2014 “North America Cardiovascular ... market data on the North America Cardiovascular Prosthetic ... of US dollars, and volume (in units) and ... categories Cardiac Valve Repairs and Septal Occluders. , ... shares data for each of these market categories, ...
(Date:7/23/2014)... dyes, George Mason University researchers discovered an innovative ... possibly leading to new treatments for cancer, arthritis, ... Mason researchers unraveled the mystery of deciphering the ... protein interlocks with another protein like adjacent pieces ... signal down the line to the next protein," ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 ... collaboration, today announce that it has joined the ... interoperability between Splashtop Enterprise and RSA SecurID® multi-factor ... EMC (EMC). , Splashtop also announced ... is now deploying Splashtop Enterprise, the industry’s only ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 On July 21, ... childhood safety advocate Jack Tracey for an episode that spoke ... the episode, Deierlein asks Tracey to talk some about the ... international in its mission, it was started right here in ... initially it was to help survivors of sexual abuse. Their ...
Breaking Medicine News(10 mins):Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5Health News:Researchers unlock the protein puzzle 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2
... Engineers have developed a new type of microchip muscle stimulator ... paralysed leg muscles. It is the first time ... is small enough to be implanted into the spinal canal ... The implant is the size of a child,s fingernail. ...
... have become aware of the dangers of excessive fructose in ... of the Journal of the American Society of Nephrology ... sugar may be. Richard J. Johnson, MD and ... of Colorado) provide a concise overview of recent clinical and ...
... Nov. 22 (HealthDay News) -- Women who were sexually or ... problems, researchers say. In the study, researchers analyzed data ... U.S. National Alcohol Survey. The investigators found that women who ... more likely to also report that they drank four or ...
... , MONDAY, Nov. 22 (HealthDay News) -- The approximately ... each year in the United States cost the health care ... Control and Prevention said in its annual STD report released ... burden of STDs but there are some signs of progress, ...
... EDITOR,S PICK: Who is in your poo? ... Pamer, Carles Ubdea, and colleagues, at Memorial Sloan-Kettering ... suggest that high-throughput DNA sequencing of bacteria in ... life-threatening bloodstream infection with the antibiotic-resistant bacterium vancomycin-resistant ...
... Alexandria, Va. The American Association for Dental Research (AADR) ... the Washington, DC, area. This year, the theme was the ... & Clinical Frontiers. The symposium was sold-out, but AADR also ... AADR created the Fall Focused Symposium under the objective ...
Cached Medicine News:Health News:New spinal implant will help people with paraplegia to exercise paralyzed limbs 2Health News:Girls Who Suffer Child Abuse May Abuse Alcohol as Adults 2Health News:New STD Report Finds Some Progress, High Costs for U.S. 2Health News:JCI table of contents: Nov. 22, 2010 2Health News:JCI table of contents: Nov. 22, 2010 3Health News:JCI table of contents: Nov. 22, 2010 4Health News:JCI table of contents: Nov. 22, 2010 5Health News:JCI table of contents: Nov. 22, 2010 6Health News:JCI table of contents: Nov. 22, 2010 7Health News:JCI table of contents: Nov. 22, 2010 8Health News:JCI table of contents: Nov. 22, 2010 9Health News:JCI table of contents: Nov. 22, 2010 10Health News:JCI table of contents: Nov. 22, 2010 11Health News:JCI table of contents: Nov. 22, 2010 12Health News:Cutting-edge salivary diagnostics research presented at AADR 3rd Fall Focused Symposium 2
Townsend is a endocervical stainless-steel curette with round tapered tip....
...
...
...
Medicine Products: